92 related articles for article (PubMed ID: 6840121)
1. A review of the long-term effects of prazosin and hydralazine in chronic congestive heart failure.
Rutishauser W
Eur Heart J; 1983 Jan; 4 Suppl A():149-52. PubMed ID: 6840121
[TBL] [Abstract][Full Text] [Related]
2. Hydralazine-induced tachycardia and sodium retention in heart failure. Hemodynamic and symptomatic correction by prazosin therapy.
Laslett LJ; DeMaria AN; Amsterdam EA; Mason DT
Arch Intern Med; 1978 May; 138(5):819-20. PubMed ID: 646547
[TBL] [Abstract][Full Text] [Related]
3. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
[TBL] [Abstract][Full Text] [Related]
4. Prazosin and congestive heart failure: short- and long-term therapy.
Rouleau JL; Warnica JW; Burgess JH
Am J Med; 1981 Jul; 71(1):147-52. PubMed ID: 7246572
[TBL] [Abstract][Full Text] [Related]
5. Chronic heart failure in the elderly: vasodilator therapy.
Satinsky JD
Angiology; 1983 Aug; 34(8):509-16. PubMed ID: 6412599
[TBL] [Abstract][Full Text] [Related]
6. Ambulatory prazosin treatment of chronic congestive heart failure: development of late tolerance reversible by higher dosage and interrupted substitution therapy.
Awan NA; Lee G; DeMaria AN; Mason DT
Am Heart J; 1981 May; 101(5):541-7. PubMed ID: 7223594
[TBL] [Abstract][Full Text] [Related]
7. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
[TBL] [Abstract][Full Text] [Related]
8. [The extension of heart failure therapy with vasodilators].
Assmann I
Z Gesamte Inn Med; 1990 Jun; 45(12):352-6. PubMed ID: 2201132
[TBL] [Abstract][Full Text] [Related]
9. Long-term vasodilator therapy for heart failure: clinical response and its relationship to hemodynamic measurements.
Massie B; Ports T; Chatterjee K; Parmley W; Ostland J; O'Young J; Haughom F
Circulation; 1981 Feb; 63(2):269-78. PubMed ID: 6778625
[TBL] [Abstract][Full Text] [Related]
10. Long-term maintenance therapy with prazosin in congestive heart failure.
Mehta J; Miles D; Iacona M; Conti CR
Clin Cardiol; 1981 May; 4(3):139-45. PubMed ID: 6790215
[TBL] [Abstract][Full Text] [Related]
11. Vasodilator therapy.
Sutton FJ
Am J Med; 1986 Feb; 80(2B):54-8. PubMed ID: 3511697
[TBL] [Abstract][Full Text] [Related]
12. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
Loeb HS; Johnson G; Henrick A; Smith R; Wilson J; Cremo R; Cohn JN
Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
[TBL] [Abstract][Full Text] [Related]
13. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
[TBL] [Abstract][Full Text] [Related]
14. [Peripheral vasodilators in the treatment of hypertension. A review].
Rasmussen K
Ugeskr Laeger; 1979 Jan; 141(5):312-4. PubMed ID: 760314
[No Abstract] [Full Text] [Related]
15. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II. The V-HeFT VA Cooperative Studies Group.
Ziesche S; Cobb FR; Cohn JN; Johnson G; Tristani F
Circulation; 1993 Jun; 87(6 Suppl):VI56-64. PubMed ID: 8500241
[TBL] [Abstract][Full Text] [Related]
16. Vasodilator therapy of chronic congestive heart failure.
Cabaniss CD
J Med Assoc Ga; 1980 Feb; 69(2):131-2. PubMed ID: 7373170
[No Abstract] [Full Text] [Related]
17. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH
Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
[No Abstract] [Full Text] [Related]
18. New approaches to therapy of acute heart failure.
Segal BL
Am Fam Physician; 1980 Feb; 21(2):131-5. PubMed ID: 7352386
[TBL] [Abstract][Full Text] [Related]
19. Hydralazine and prazosin in the treatment of hypertension.
Vandenburg MJ; Sharman VL; Wright P; Drew PJ; Barnes JN
Br J Clin Pharmacol; 1983 Nov; 16(5):537-42. PubMed ID: 6357257
[TBL] [Abstract][Full Text] [Related]
20. [Vasodilator treatment of chronic heart failure: a chronic double-blind trial with prazosin and erythrityl tetranitrate].
Tomov I; Kaloianova A; Terzieva L; Elenkova A; Nikolov G
Vutr Boles; 1981; 20(6):72-8. PubMed ID: 7039130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
